[HTML][HTML] Living on the edge of the CNS: meninges cell diversity in health and disease

J Derk, HE Jones, C Como, B Pawlikowski… - Frontiers in cellular …, 2021 - frontiersin.org
The meninges are the fibrous covering of the central nervous system (CNS) which contain
vastly heterogeneous cell types within its three layers (dura, arachnoid, and pia). The dural …

Leptomeningeal metastasis from systemic cancer: review and update on management

N Wang, MS Bertalan, PK Brastianos - Cancer, 2018 - Wiley Online Library
Leptomeningeal metastasis is an uncommon and typically late complication of cancer with a
poor prognosis and limited treatment options. Diagnosis is often challenging, with …

[HTML][HTML] Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis

A Boire, Y Zou, J Shieh, DG Macalinao, E Pentsova… - Cell, 2017 - cell.com
We molecularly dissected leptomeningeal metastasis, or spread of cancer to the
cerebrospinal fluid (CSF), which is a frequent and fatal condition mediated by unknown …

[HTML][HTML] Carcinomatous meningitis: leptomeningeal metastases in solid tumors

E Le Rhun, S Taillibert… - Surgical neurology …, 2013 - ncbi.nlm.nih.gov
Leptomeningeal metastasis (LM) results from metastatic spread of cancer to the
leptomeninges, giving rise to central nervous system dysfunction. Breast cancer, lung …

Leptomeningeal metastases in the MRI era

JL Clarke, HR Perez, LM Jacks, KS Panageas… - Neurology, 2010 - AAN Enterprises
Background: Diagnosis of leptomeningeal metastasis (LM) has become increasingly
frequent. The diagnostic gold standard has been CSF cytology, but MRI is now used …

Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis

PK Brastianos, EQ Lee, JV Cohen, SM Tolaney… - Nature medicine, 2020 - nature.com
An increasing fraction of patients with metastatic cancer develop leptomeningeal
dissemination of disease (LMD), and survival is dismal,–. We conducted a single-arm, phase …

Leptomeningeal metastasis

MC Chamberlain - Seminars in neurology, 2010 - thieme-connect.com
Leptomeningeal metastasis occurs in~ 5% of all patients with cancer and is the third most
common metastatic complication of the central nervous system. Staging of leptomeningeal …

[HTML][HTML] Leptomeningeal metastasis: clinical experience of 519 cases

JW Hyun, IH Jeong, AR Joung, HJ Cho, SH Kim… - European Journal of …, 2016 - Elsevier
Background Diagnosis of leptomeningeal metastasis (LM) has become increasingly
common because of enhanced detection via routine use of magnetic resonance imaging …

Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials

M Chamberlain, R Soffietti, J Raizer, R Ruda… - Neuro …, 2014 - academic.oup.com
Purpose To date, response criteria and optimal methods for assessment of outcome have
not been standardized in patients with leptomeningeal metastasis (LM). Methods A …

Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era

JH Park, YJ Kim, JO Lee, KW Lee, JH Kim, SM Bang… - Lung Cancer, 2012 - Elsevier
BACKGROUND: We analyzed the patterns of treatment and clinical outcomes of
leptomeningeal metastasis (LM) in patients with non-small cell lung cancer (NSCLC) in the …